Home / Support & Resources
Support & Resources
Reputable organizations and medical references for patients, caregivers, and families. You are not alone.
A note about these links
These are independent organizations. Lotus of Hope is not affiliated with them, and listing them is not an endorsement. We checked that each link worked in November 2026. Information here is for awareness only — please talk to your healthcare team about medical decisions.
Pheo Para patient organization
- Pheo Para Alliance
The patient advocacy organization for pheochromocytoma and paraganglioma: education, newly diagnosed care kits, advocacy, and research.
- Pheo Para Alliance — Get Support
Ways to connect with others, find experienced doctors, and locate assistance with expenses and travel.
- Pheo Para Alliance — Peer Navigation Support
One-on-one peer support and an online monthly peer support meeting for patients and caregivers.
- Pheo Para Alliance — Centers of Excellence
Specialized centers with multidisciplinary pheo para expertise.
- Pheo Para Alliance — Downloadable resources
Educational guides, metanephrine testing guides, and doctor-visit worksheets.
- Pheo Para Alliance — Frequently asked questions
Answers to common questions about pheo para.
- Pheo Para Alliance — Pheo Para in Kids
Information about pheochromocytoma and paraganglioma in children.
- Pheo Para Alliance — Clinical trials finder
Help finding clinical trials for pheo para.
Medical information (patient-friendly)
- National Cancer Institute — Pheochromocytoma and Paraganglioma (patient version)
Expert-reviewed summary of causes, symptoms, diagnosis, and treatment.
- NCI — Pheochromocytoma (rare tumors)
Overview from NCI’s Center for Cancer Research.
- MedlinePlus — Pheochromocytoma
From the U.S. National Library of Medicine (NIH).
- Mayo Clinic — Symptoms and causes
Overview of symptoms, spells, triggers, and when to see a doctor.
- Mayo Clinic — Diagnosis and treatment
Tests, surgery, and follow-up.
- Cleveland Clinic — Pheochromocytoma
Health library article on symptoms, causes, and treatment.
- NICHD (NIH) — What causes pheochromocytoma?
The role of genetics.
- NORD — Pheochromocytoma/Paraganglioma
National Organization for Rare Disorders rare disease report; NORD also runs a helpline (1-800-999-6673).
- Genetic and Rare Diseases Information Center (GARD)
NIH center with information for patients and families living with rare diseases.
Genetics & family
- Find a Genetic Counselor — National Society of Genetic Counselors
Search for a genetic counselor near you or by telehealth.
- MedlinePlus Genetics — Nonsyndromic paraganglioma
Genetics overview for paraganglioma.
- Association for Multiple Endocrine Neoplasia Disorders (AMEND)
Support organization for MEN disorders, a group of inherited conditions that can include pheochromocytoma (UK-based).
Related patient organizations
- NET Research Foundation
Neuroendocrine tumor research and patient information.
- International Neuroendocrine Cancer Alliance (INCA) — NET Cancer Day
Global alliance behind NET Cancer Day (November 10), which includes pheochromocytoma and paraganglioma; the zebra is its symbol.
- National Adrenal Diseases Foundation
Support and information for people with adrenal diseases.
Clinical trials
- ClinicalTrials.gov
The U.S. National Library of Medicine’s registry of clinical studies.
- NCI — About clinical trials
How trials work. NCI’s Cancer Information Service can also help: 1-800-4-CANCER (1-800-422-6237).
Emotional & financial support
- Cancer Support Community
Support groups, counseling, and education.
- CancerCare
Free counseling and support groups led by oncology social workers, plus limited financial assistance. 800-813-HOPE (4673).
- American Cancer Society
Information on health insurance, lodging, and other practical help.
Awareness dates
NET Cancer Day — November 10
Observed each year to raise awareness of neuroendocrine tumors, including pheochromocytoma and paraganglioma[1].
Pheo Para Awareness Week — late August
The Pheo Para Alliance holds an annual Awareness Week; the 2025 week was August 25–29[2]. Learn more.